The Efficacy and Safety of Anlotinib Treatment for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Who Achieved Stable Disease (SD) After Two Cycles of First-Line Chemotherapy Combined with Immunotherapy: A Retrospective Cohort Study

Wu D, Liu K, Peng Y, Liu Y, Tang J, Lin X, Li X

Cancer Management and Research 2025, 17:2795-2805

Published Date: 15 November 2025